https://www.selleckchem.com/pr....oducts/amredobresib.
With OAGB-150, PTH changes were significant at 2 years only. We found that both OAGB-200 and OAGB-150 are associated with a significant increase in anaemia and secondary hyperparathyroidism. Our findings should prompt the evaluation of supplementation protocols with higher dosages than we recommend for iron, folate and calcium. Consideration should also be given to evaluating shorter BPL lengths than 150 cm with OAGB. We found that both OAGB-200 and OAGB-150 are associated with a significant increase in anaemia and secondary hyperp
Like
Comment
Share
